ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,297.12
-0.21%
US Tech 100
18,086.00
-0.17%
Dow Jones
39,869.38
-0.10%
Brent Oil
83.105
0.54%
Bitcoin
65,214.28
-1.58%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/16/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNTYGuaranty Bancshares Inc
05/16/20244:00PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:MSSAWMetal Sky Star Acquisition Corporation
05/16/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
05/16/20244:00PMGlobeNewswire Inc.Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASHLSE:0RNKInventiva Sa
05/16/20244:00PMGlobeNewswire Inc.Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASHTG:6IVInventiva
05/16/20244:00PMGlobeNewswire Inc.Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASHEU:IVAInventiva
05/16/20244:00PMGlobeNewswire Inc.Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASHEU:IVAInventiva
05/16/20244:00PMGlobeNewswire Inc.Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASHTG:6IVInventiva
05/16/20244:00PMGlobeNewswire Inc.Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASHLSE:0RNKInventiva Sa
05/16/20244:00PMBusiness WireCareQuest Institute CEO Testifies at Senate Committee Hearing on Dental Care Crisis in US
05/16/20244:00PMBusiness WireInnovative Solutions & Support, Inc. Appoint New Board MemberNASDAQ:ISSCInnovative Solutions and Support Inc
05/16/20244:00PMPR Newswire (Canada)La Nation huronne-wendat et le gouvernement du Canada règlent la revendication relative à la réserve de Rockmont
05/16/20244:00PMPR Newswire (Canada)Avis de décision - L'OCRI sanctionne Allen Murphy
05/16/20244:00PMPR Newswire (Canada)Decision Notice - CIRO Sanctions Allen Murphy
05/16/20244:00PMPR Newswire (Canada)Huron-Wendat Nation and the Government of Canada settle claim for Rockmont Reserve
05/16/20244:00PMPR Newswire (US)JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain FintechNASDAQ:JANJanOne Inc
05/16/20243:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BCOBrinks Company
05/16/20243:59PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPMJP Morgan Chase and Co
05/16/20243:59PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BANTBantec Inc (PK)
05/16/20243:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PRUPrudential Financial Inc
05/16/20243:59PMBusiness WireMomentum Design Lab gewinnt mehrere Preise für das beste Design von digitalen Produkten
05/16/20243:59PMPR Newswire (Canada)Promutuel Assurance se classe parmi les 60 leaders en expérience employé
05/16/20243:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STBAS and T Bancorp Inc
05/16/20243:57PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BDCOBlue Dolphin Energy Company (QX)
05/16/20243:57PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BACBank of America Corporation
05/16/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DIODDiodes Inc
05/16/20243:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SBACSBA Communications Corporation
05/16/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITICInvestors Title Company
05/16/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STBAS and T Bancorp Inc
05/16/20243:57PMPR Newswire (US)Stenson Tamaddon Files Lawsuit Against IRS and Treasury Department Over Employee Retention Credit (ERC) Program

Your Recent History

NASDAQ
GWAV
Greenwave Technology Sol...
USOTC
RONN
Ronn Motor (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
PLPL
Plandai Biotechnology (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
SPZI
Spooz (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
CIVX
CTR Investments and Cons... (CE)
USOTC
CEOS
CeCors (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
NLST
Netlist (QB)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved